After Prometheus sale, Mark McKenna heads to another …
WEBAug 21, 2023 · After Mark McKenna sold a biotech for $10.8 billion, the executive recruiters likely came knocking, trying to poach the CEO who took an immunology and inflammation biotech from early-stage private financing to an IPO to key Phase II data in the span of four years.
Mark McKenna - UK Finance and Operations Director - LinkedIn
WEBView Mark McKenna’s profile on LinkedIn, a professional community of 1 billion members. UK Finance and Operations Director · Experience: Holders Technology · Location: Galashiels · 203...
- Title: UK Finance and Operations …
- Location: Holders Technology
- Connections: 203
Executive Compensation at Baylor Scott and White Health
WEBJul 26, 2019 · BSWH. The network employs approximately 47,000 individuals but BSWH reported having 2,173 employees who were compensated $453 million (about half of their total revenue) in 2016, which equates to an average compensation of $209,000.
Bausch loses Salix president—and turnaround architect—to precision GI ...
WEBSep 4, 2019 · After four years working to turn around Bausch Health's Salix Pharmaceuticals, President Mark McKenna is leaving. McKenna will this week become the CEO of a new precision medicine drug...
Mirador debuts with $400M, picking up where immune drugmaker …
WEBMar 21, 2024 · "The journey was unfinished," said Mirador CEO Mark McKenna, Prometheus’ former leader, in an interview with BioPharma Dive. Prometheus’ work led to a drug aimed at a regulatory protein, TL1A, that’s implicated in inflammatory bowel disease.
Biography of Mark McKenna - The Official Board
WEBLearn about the role of Mark McKenna, Vice President of Health, Safety, Security and Environmental at Venture Global LNG. Full bio on The Official Board.
| BioWorld
WEBApr 23, 2024 · In one of the biggest financings of the year so far, former Prometheus Biosciences Inc. CEO Mark McKenna helped raise $400 million to launch a new company, Mirador Therapeutics Inc. He didn’t sit on the sidelines for long after Merck & Co. Inc. bought Prometheus for $10.8 billion in 2023.
Former Prometheus execs raise $400M for precision immunology …
WEBMar 21, 2024 · Mark McKenna, Mirador Therapeutics CEO. March 21, 2024 07:00 AM EDT. Financing. Startups. Former Prometheus execs raise $400M for precision immunology startup: 'The band is back...
Mark McKenna email address & phone number - RocketReach
WEBMark McKenna, based in Galashiels, GB, is currently a UK Finance and Operations Director at Holders Technology, bringing experience from previous roles at BSW Timber Ltd, Spark Energy UK and Spark Energy Ltd. Mark McKenna holds a 1992 - 1996 MA (HONS) in Economics and Accountancy @ The University of Edinburgh.
Amazon’s Quiet Overhaul of the Trademark System
WEBAmazon’s dominance as a platform is widely documented. But one aspect of that dominance has not received much attention — the Amazon Brand Registry’s sweeping influence on firm behavior, particularly in relation to the formal trademark system. As UCLA Law Vice Dean Mark P. McKenna will explain, Amazon’s Brand Registry serves as a shadow trademark system that dramatically affects ...
Skip to content